Citation: Md. Kraus et al., SPLENIC PATHOLOGY IN MYELODYSPLASIA - A REPORT OF 13 CASES WITH CLINICAL CORRELATION, The American journal of surgical pathology, 22(10), 1998, pp. 1255-1266
Authors:
NAUGHTON MJ
HESS JL
ZUTTER MM
BARTLETT NL
Citation: Mj. Naughton et al., BONE-MARROW STAGING IN PATIENTS WITH NON-HODGKINS-LYMPHOMA - IS FLOW-CYTOMETRY A USEFUL TEST, Cancer, 82(6), 1998, pp. 1154-1159
Citation: Je. Mortimer et Nl. Bartlett, ASSESSMENT OF KNOWLEDGE ABOUT CANCER PAIN MANAGEMENT BY PHYSICIANS IN-TRAINING, Journal of pain and symptom management, 14(1), 1997, pp. 21-28
Authors:
PHUNG NX
BARTLETT NL
FRACASSO PM
PIWNICAWORMS D
ROYAL HD
Citation: Nx. Phung et al., IN-VIVO QUANTIFICATION OF THE EFFECT OF P-GLYCOPROTEIN INHIBITOR PSC833 ON THE BIOKINETICS OF TC-99M SESTAMIBI, The Journal of nuclear medicine, 38(5), 1997, pp. 1022-1022
Authors:
HORNING SJ
BENNETT JM
BARTLETT NL
WILLIAMS J
NEUBERG D
CASSILETH PA
Citation: Sj. Horning et al., 12 WEEKS OF CHEMOTHERAPY (STANFORD V) AND INVOLVED FIELD RADIOTHERAPY(RT) ARE HIGHLY EFFECTIVE FOR BULKY AND ADVANCED-STAGE HODGKINS-DISEASE (HD) - A LIMITED INSTITUTION ECOG PILOT-STUDY, Blood, 88(10), 1996, pp. 2681-2681
Citation: Nl. Bartlett et al., BRIEF CHEMOTHERAPY, STANFORD-V, AND ADJUVANT RADIOTHERAPY FOR BULKY OR ADVANCED-STAGE HODGKINS-DISEASE - A PRELIMINARY-REPORT, Journal of clinical oncology, 13(5), 1995, pp. 1080-1088
Authors:
BARTLETT NL
LUM BL
FISHER GA
BROPHY NA
EHSAN MN
HALSEY J
SIKIC BI
Citation: Nl. Bartlett et al., PHASE-I TRIAL OF DOXORUBICIN WITH CYCLOSPORINE AS A MODULATOR OF MULTIDRUG-RESISTANCE, Journal of clinical oncology, 12(4), 1994, pp. 835-842
Authors:
LUM BL
BARTLETT NL
FISHER GA
BROPHY NA
EHSAN M
HALSEY J
SIKIC BI
Citation: Bl. Lum et al., PHARMACODYNAMICS (PD) OF DOXORUBICIN (DOX) WITH CYCLOSPORINE (CSA) ASA MODULATOR OF DRUG-RESISTANCE, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 210-210
Citation: Nl. Bartlett et al., MACOP-B + - RADIATION-THERAPY FOR DIFFUSE LARGE-CELL LYMPHOMA - ANALYSIS OF THE STANFORD RESULTS ACCORDING TO PROGNOSTIC INDEXES/, Cancer, 71(12), 1993, pp. 4034-4042